DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Weber-Schoendorfer C, Oppermann M, Wacker E, Bernard N, on behalf of the network of French pharmacovigilance centers, Beghin D, Cuppers-Maarschalkerweerd B, Richardson J, Rothuizen LE, Pistelli A, Malm H, Eleftheriou G, Kennedy D, Kadıoglu M, Meister R, Schaefer C.
Increased risk of birth defects after TNF-α inhibitor therapy during pregnancy? A prospective multicenter cohort study.
Birth Defects Research 2013; (im Druck)
We do not assume any responsibility for the contents of the web pages of other providers.